Cargando…
Risk and characteristics of tuberculosis after anti-tumor necrosis factor therapy for inflammatory bowel disease: a hospital-based cohort study from Korea
BACKGROUND: Anti-tumor necrosis factor (TNF) treatment for inflammatory bowel disease (IBD) increases the risk of tuberculosis (TB) infection. In the present study, we analyzed the clinical characteristics and risks of TB in Korean patients with IBD who received anti-TNF treatment. METHODS: The stud...
Autores principales: | Lee, Jae Yong, Oh, Kyunghwan, Hong, Hee Seung, Kim, Kyuwon, Hong, Seung Wook, Park, Jin Hwa, Hwang, Sung Wook, Yang, Dong-Hoon, Ye, Byong Duk, Byeon, Jeong-Sik, Myung, Seung-Jae, Yang, Suk-Kyun, Lee, Ho-Su, Jo, Kyung-Wook, Park, Sang Hyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527666/ https://www.ncbi.nlm.nih.gov/pubmed/34670529 http://dx.doi.org/10.1186/s12876-021-01973-5 |
Ejemplares similares
-
Frequency of Positive Conversion of Interferon-Gamma Release Assay Results Among Patients With Inflammatory Bowel Disease Treated With Non-tumor Necrosis Factor Inhibitors
por: Kim, Kyuwon, et al.
Publicado: (2021) -
Short-term tolerability and effectiveness of methotrexate monotherapy
in adult patients with Crohn’s disease: a retrospective study
por: Hong, Hee Seung, et al.
Publicado: (2021) -
Oral beclomethasone dipropionate as an add-on therapy and response prediction in Korean patients with ulcerative colitis
por: Kim, Kyuwon, et al.
Publicado: (2022) -
Clinical Course of COVID-19 in Patients with Inflammatory Bowel Disease in Korea: a KASID Multicenter Study
por: Lee, Jin Wook, et al.
Publicado: (2021) -
Seroprevalence of viral infectious diseases and associated factors in Korean patients with inflammatory bowel diseases
por: Hong, Hee Seung, et al.
Publicado: (2022)